Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $17.17.

A number of brokerages recently weighed in on ALHC. JPMorgan Chase & Co. boosted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Stifel Nicolaus boosted their target price on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th. UBS Group boosted their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Finally, Barclays boosted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research note on Friday, February 28th.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $13.96 on Monday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 2.95. Alignment Healthcare has a fifty-two week low of $7.19 and a fifty-two week high of $21.06. The firm has a 50-day simple moving average of $15.90 and a 200 day simple moving average of $15.00. The company has a market cap of $2.76 billion, a PE ratio of -29.08 and a beta of 1.22.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The business had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same quarter in the prior year, the firm earned ($0.25) EPS. The company's revenue for the quarter was up 47.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Alignment Healthcare will post -0.69 EPS for the current year.

Insider Activity at Alignment Healthcare

In related news, CEO John E. Kao sold 90,000 shares of the company's stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $14.48, for a total value of $1,303,200.00. Following the completion of the sale, the chief executive officer now owns 1,733,100 shares in the company, valued at approximately $25,095,288. This represents a 4.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $14.48, for a total transaction of $434,400.00. Following the completion of the sale, the president now owns 2,072,899 shares of the company's stock, valued at approximately $30,015,577.52. This trade represents a 1.43% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,875,452 shares of company stock valued at $274,429,595 over the last ninety days. Insiders own 6.60% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. MCF Advisors LLC increased its stake in Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after buying an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new position in Alignment Healthcare in the 1st quarter valued at approximately $42,000. Amalgamated Bank increased its stake in Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares during the period. RiverPark Advisors LLC acquired a new position in Alignment Healthcare in the 4th quarter valued at approximately $106,000. Finally, Tower Research Capital LLC TRC increased its stake in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares during the period. Institutional investors and hedge funds own 86.19% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.